Arcturus Therapeutics

Arcturus Therapeutics News & Events
Daniel Geffken, MBA

Daniel Geffken, MBA

Director
Prior to joining the Arcturus Therapeutics Ltd. Board, Dr. Geffken had served on the Alcobra Board since their initial public offering in May 2013. Since October 2011, he has been Managing Director of Danforth Advisors, LLC, a management consulting firm that provides financial and strategic support to emerging life science companies. Mr. Geffken has also been Chief Financial Officer or Chief Operating Officer of eight companies, four of which were U.S. public reporting companies and six of which were life science companies. He has a B.S. in Economics from The Wharton School, University of Pennsylvania, and a M.B.A. from Harvard Business School.